Lesion Detectability and Clinical Effectiveness of Dual-head Coincidence Gamma Camera Imaging in Comparison with Dedicated PET Systems in Tumour Patients

Abstract

The lesion detection capability and clinical effectiveness of dual-head coincidence gamma camera imaging (c-PET) were compared with those of dedicated positron emission tomography (d-PET) in 37 cancer patients who underwent whole-body c-PET and d-PET imaging after administration of 370 − 540 MBq ¹⁸F-fluorodeoxyglucose. Eighty-nine lesions were detected on c-PET whereas 133 lesions were seen with d-PET imaging. The relative sensitivity of c-PET compared with d-PET was 62% and 73% for lesions < 15 and ≤ 15 mm, respectively, and the relative concordance rate was 84% when the patients were restaged. Since the lesion detection rate of c-PET imaging was lower than that of d-PET, the detection of small lesions, therefore, requires care. The clinical effectiveness of c-PET, however, was similar to that of d-PET and, therefore, it is concluded that c-PET can be used as an alternative to d-PET, particularly considering the high cost and limited availability of d-PET cameras.

Keywords

Cancer Dual-head coincidence gamma camera Dedicated PET Diagnostic imaging

References

Conti

Lilien

Hawley

: PET and [18-F]FDG in clinical oncology: A clinical update. Nucl Med Biol 1996; 23: 717–735.

Delbeke

Sandler

: Positron emission tomography imaging in oncology. Radiol Clin North Am 2001; 39: 883–917.

Jerusalem

Hustinx

Beguin

: PET scan imaging in oncology. Eur J Cancer 2003; 39: 1525–1534.

Macfarlane

Cotton

Ackermann

: Triple-head SPECT with 2- [fluorine-18] fluoro-2-deoxy-D-glucose (FGD): Initial evaluation in oncology and comparison with FDG PET. Radiology 1995; 194: 425–429.

Tatsumi

Kitayama

Sugahara

: Whole-body hybrid PET with ¹⁸F-FDG in the staging of non-Hodgkin's lymphoma. J Nucl Med 2001; 42: 609–610.

D'Asseler

Vanderberge

Winter

: PET imaging using gamma cameras. Comput Med Imaging Graph 2001; 25: 87–96.

Coleman

Laymon

Turkington

: FDG imaging of lung nodules: A phantom study comparing SPECT, camera-based PET, and dedicated PET. Radiology 1999; 210: 823–828.

Lewellen

Miyaoka

Swan

: PET imaging using dual-headed gamma cameras: An update. Nucl Med Commun 1999; 20: 5–12.

Boren

Delbeke

Patton

: Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8 inch NaI(Tl) crystals in patients with suspected body malignancies. Eur J Nucl Med 1999; 26: 379–387.

10.

Blokland

Pauwels

JKE

: The clinical value of ¹⁸F-FDG detection with a dual-head coincidence camera: a review. Eur J Nucl Med 2001; 28: 763–778.

11.

Pai

Park

Suh

: Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer. Clin Nucl Med 1999; 24: 495–500.

12.

Weber

Neverve

Sklarek

: Imaging of lung cancer with fluorine-18 fluorodeoxyglucose dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system. Eur J Nucl Med 1999; 26: 388–395.

13.

Landoni

Lucignani

G Gianolli

Magnani

: Comparison of dual-head coincidence PET versus ring PET in tumor patients J Nucl Med 1999; 40: 1617–1622.

14.

Zimny

Kaiser

Cremerius

: Dual-head gamma camera 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: Effect of non-uniform attenuation correction on lesion detection. Eur J Nucl Med 1999; 26: 818–823.

15.

Shreve

Steventon

Deters

: Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431–437.

16.

Kubota

Yokoyama

Yamaguchi

: FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: Comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004; 31: 590–595.